Onderneming Recursion Pharmaceuticals, Inc.
Aandelen
RXRX
US75629V1044
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,35 USD | -0,68% | -12,60% | -25,46% |
Vakgebied
Aantal werknemers: 500
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Drug Discovery
100,0
%
| 40 | 100,0 % | 45 | 100,0 % | +11,88% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 40 | 100,0 % | 45 | 100,0 % | +11,88% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 41 | 05-11-13 | |
Blake Borgeson
FOU | Founder | 42 | 05-11-13 |
Dean Li
FOU | Founder | 62 | 05-11-13 |
Tina Larson
PSD | President | 49 | 01-07-18 |
Michael Secora
DFI | Director of Finance/CFO | 41 | 01-03-20 |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | - | 16-08-21 | |
Benjamin Mabey
CTO | Chief Tech/Sci/R&D Officer | 41 | 01-03-17 |
Laura Schaevitz
CTO | Chief Tech/Sci/R&D Officer | - | - |
David Mauro
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-06-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 20-03-20 |
Chairman | 60 | 01-04-20 | |
Dean Li
FOU | Founder | 62 | 05-11-13 |
Blake Borgeson
FOU | Founder | 42 | 05-11-13 |
Zachary Bogue
BRD | Director/Board Member | 48 | 01-08-18 |
Zavain Dar
BRD | Director/Board Member | 35 | 01-09-16 |
Founder | 41 | 05-11-13 | |
Director/Board Member | 47 | 01-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 10 | 7 509 871 | 0 | 0 | 91,33 % |
Aandeel B | 1 | 227 143 401 | 214 303 158 ( 94,35 %) | 0 |
Bedrijfsgegevens
Recursion Pharmaceuticals, Inc.
41 South Rio Grande Street
84101, Salt Lake City
+
http://www.recursion.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,46% | 1,74 mld. | |
-3,10% | 102 mld. | |
+2,11% | 96,07 mld. | |
-1,80% | 21,66 mld. | |
-17,75% | 20,77 mld. | |
-6,91% | 18,53 mld. | |
-42,00% | 16,91 mld. | |
-28,19% | 13,79 mld. | |
+0,18% | 13,33 mld. | |
+19,90% | 10,94 mld. |
- Beurs
- Aandelen
- Koers RXRX
- Onderneming Recursion Pharmaceuticals, Inc.